cyclonerodiol has been researched along with Asthma, Bronchial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erkel, G; Rudolph, AK; Walter, T | 1 |
| Erkel, G; Langhanki, J; Opatz, T; Rudolph, K | 1 |
2 other study(ies) available for cyclonerodiol and Asthma, Bronchial
| Article | Year |
|---|---|
The fungal metabolite cyclonerodiol inhibits IL-4/IL-13 induced Stat6-signaling through blocking the association of Stat6 with p38, ERK1/2 and p300.
Topics: A549 Cells; Acetylation; Asthma; Humans; Interleukin-13; Interleukin-4; MAP Kinase Signaling System; p300-CBP Transcription Factors; p38 Mitogen-Activated Protein Kinases; Respiratory Mucosa; Sesquiterpenes; STAT6 Transcription Factor; Trans-Activators; Transcriptional Activation | 2018 |
Total synthesis and biological evaluation of the natural product (-)-cyclonerodiol, a new inhibitor of IL-4 signaling.
Topics: Acyclic Monoterpenes; Anti-Allergic Agents; Asthma; Cell Line; Cyclization; Humans; Interleukin-4; Monoterpenes; Sesquiterpenes; Signal Transduction; STAT6 Transcription Factor | 2014 |